136 related articles for article (PubMed ID: 1301968)
1. Antiphospholipid antibodies differ in aPL cofactor requirement.
Sammaritano LR; Lockshin MD; Gharavi AE
Lupus; 1992 Feb; 1(2):83-90. PubMed ID: 1301968
[TBL] [Abstract][Full Text] [Related]
2. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
3. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies bind ATP: a putative mechanism for the pathogenesis of neuronal dysfunction.
Chapman J; Soloveichick L; Shavit S; Shoenfeld Y; Korczyn AD
Clin Dev Immunol; 2005 Sep; 12(3):175-80. PubMed ID: 16295522
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
7. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
Wagenknecht DR; McIntyre JA
Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
[TBL] [Abstract][Full Text] [Related]
8. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil HP; Simpson RJ; Chesterman CN; Krilis SA
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4120-4. PubMed ID: 2349221
[TBL] [Abstract][Full Text] [Related]
9. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
[TBL] [Abstract][Full Text] [Related]
10. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
12. Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity.
Celli CM; Gharavi AE; Chaimovich H
Biochim Biophys Acta; 1999 Jan; 1416(1-2):225-38. PubMed ID: 9889373
[TBL] [Abstract][Full Text] [Related]
13. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
Valesini G; Shoenfeld Y
Autoimmunity; 1992; 14(2):105-10. PubMed ID: 1303677
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D; Sánchez-Guerrero J
J Autoimmun; 1992 Dec; 5(6):787-801. PubMed ID: 1489489
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid cofactor.
Gharavi AE
Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
[TBL] [Abstract][Full Text] [Related]
16. Lipid interactions with human antiphospholipid antibody, beta 2-glycoprotein 1, and normal human IgG using the fluorescent probes NBD-PE and DPH.
Tang D; Borchman D; Harris N; Pierangeli S
Biochim Biophys Acta; 1998 Jun; 1372(1):45-54. PubMed ID: 9651477
[TBL] [Abstract][Full Text] [Related]
17. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
19. The interaction of beta 2 glycoprotein-I and heparin and its effect on beta 2 glycoprotein-I antiphospholipid antibody cofactor function in plasma.
McNally T; Cotterell SE; Mackie IJ; Isenberg DA; Machin SJ
Thromb Haemost; 1994 Oct; 72(4):578-81. PubMed ID: 7878636
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies: new perspectives on antigenic specificity.
Jones JV
J Rheumatol; 1992 Nov; 19(11):1774-7. PubMed ID: 1283412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
